panadol extra 500mg/65mg soluble effervescent tablets
glaxosmithkline consumer healthcare (ireland) limited 12, riverwalk, citywest business campus, dublin 24, ireland - caffeine, paracetamol - effervescent tablet - caffeine 65 mg paracetamol 500 mg - analgesics
adjupanrix (previously pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals)
glaxosmithkline biologicals s.a. - split influenza virus, inactivated, containing antigen: a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14) - influenza, human - vaccines - prophylaxis of influenza in an officially declared pandemic situation. pandemic influenza vaccine should be used in accordance with official guidance.
solpadeine tablets
glaxosmithkline dungarvan limited - paracetamol, caffeine, codeine (codeine phosphate) - tablets - 500mg+ 30mg+ 8mg
solpadeine active tablets soluble
glaxosmithkline dungarvan limited - paracetamol, caffeine - tablets soluble - 500mg+ 65mg
niquitin minis orange 1.5mg lozenges
omega pharma ltd - nicotine - compressed lozenge - 1.5mg - drugs used in nicotine dependence - niquitin minis 1.5 mg lozenges relieve and/or prevent craving and nicotine withdrawal symptoms associated with tobacco dependence. they are indicated to aid smokers wishing to quit or reduce prior to quitting, to assist smokers who are unwilling or unable to smoke, and as a safer alternative to smoking for smokers and those around them. niquitin minis 1.5 mg lozenges are indicated in pregnant and lactating women making a quit attempt. niquitin minis 1.5 mg lozenges should preferably be used in conjunction with a behavioural support programme
niquitin minis mint 1.5mg lozenges
omega pharma ltd - nicotine - compressed lozenge - 1.5mg - drugs used in nicotine dependence. - iquitin minis 1.5 mg lozenges relieve and/or prevent craving and nicotine withdrawal symptoms associated with tobacco dependence. they are indicated to aid smokers wishing to quit or reduce prior to quitting, to assist smokers who are unwilling or unable to smoke, and as a safer alternative to smoking for smokers and those around them. niquitin minis 1.5 mg lozenges are indicated in pregnant and lactating women making a quit attempt. niquitin minis mint 1.5 mg lozenges should preferably be used in conjunction with a behavioural support programme.
niquitin minis mint 4mg lozenges
omega pharma ltd - nicotine - compressed lozenge - 4mg - drugs used in nicotine dependence - niquitin minis 4 mg lozenges relieve and/or prevent craving and nicotine withdrawal symptoms associated with tobacco dependence. they are indicated to aid smokers wishing to quit or reduce prior to quitting, to assist smokers who are unwilling or unable to smoke, and as a safer alternative to smoking for smokers and those around them. niquitin minis 4 mg lozenges are indicated in pregnant and lactating women making a quit attempt.
apfen plus 200/12.8 milligram film coated tablet
glaxosmithkline consumer healthcare (ireland) limited - ibuprofen, codeine phosphate hemihydrate - film coated tablet - 200/12.8 milligram - codeine and ibuprofen
panadol actifast tablets 500mg
glaxosmithkline consumer healthcare (ireland) limited - paracetamol - film-coated tablet - 500 milligram(s) - anilides; paracetamol
fortum 2 gram
novartis israel ltd., israel - ceftazidime as pentahydrate - powder for solution for inj/inf - ceftazidime as pentahydrate 2 g/vial - ceftazidime - ceftazidime - fortum is indicated for the treatment of the infections listed below in adults and children including neonates (from birth).• nosocomial pneumonia• broncho-pulmonary infections in cystic fibrosis• bacterial meningitis• chronic suppurative otitis media• malignant otitis externa• complicated urinary tract infections• complicated skin and soft tissue infections• complicated intra-abdominal infections• bone and joint infections• peritonitis associated with dialysis in patient on capd.treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above.ceftazidime may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.ceftazidime may be used in the peri-operative prophylaxis of urinary tract infections for patients undergoing trans-urethral resection of the prostate (turp).the selection of ceftazidime should take into account its antibacterial spectrum, which is mainly restricted to aerobic gram negative bacteria.ceftazidime should be co-administered with other antibacterial agents whenever the possible range of causive bacteria would not fall within its spectrum of activity.consideration should be given to official guidelines on the appropriate use of antibacterial agents.